1
|
Davies MJ, D'Alessio DA, Fradkin J, Kernan
WN, Mathieu C, Mingrone G, Rossing P, Tsapas A, Wexler DJ and Buse
JB: Management of hyperglycemia in type 2 diabetes, 2018. A
consensus report by the american diabetes association (ADA) and the
European association for the study of diabetes (EASD). Diabetes
Care. 41:2669–2701. 2018. View Article : Google Scholar : PubMed/NCBI
|
2
|
Nickerson HD and Dutta S: Diabetic
complications: Current challenges and opportunities. J Cardiovasc
Transl Res. 5:375–379. 2012. View Article : Google Scholar : PubMed/NCBI
|
3
|
Meldgaard T, Olesen SS, Farmer AD, Krogh
K, Wendel AA, Brock B, Drewes AM and Brock C: Diabetic enteropathy:
From molecule to mechanism-based treatment. J Diabetes Res.
2018:38273012018. View Article : Google Scholar : PubMed/NCBI
|
4
|
de Kort S, Simons C, van den Brandt PA,
Janssen-Heijnen MLG, Sanduleanu S, Masclee AAM and Weijenberg MP:
Diabetes mellitus, genetic variants in the insulin-like growth
factor pathway and colorectal cancer risk. Int J Cancer.
145:1774–1781. 2019.PubMed/NCBI
|
5
|
Wang X, Häring MF, Rathjen T, Lockhart SM,
Sørensen D, Ussar S, Rasmussen LM, Bertagnolli MM, Kahn CR and
Rask-Madsen C: Insulin resistance in vascular endothelial cells
promotes intestinal tumour formation. Oncogene. 36:4987–4996. 2017.
View Article : Google Scholar : PubMed/NCBI
|
6
|
Pirogov SA, Gvozdev VA and Klenov MS: Long
noncoding RNAs and stress response in the nucleolus. Cells.
8:E6682019. View Article : Google Scholar : PubMed/NCBI
|
7
|
Rafiee A, Riazi-Rad F, Havaskary M and
Nuri F: Long noncoding RNAs: Regulation, function and cancer.
Biotechnol Genet Eng Rev. 34:153–180. 2018. View Article : Google Scholar : PubMed/NCBI
|
8
|
Klingenberg M, Matsuda A, Diederichs S and
Patel T: Non-coding RNA in hepatocellular carcinoma: Mechanisms,
biomarkers and therapeutic targets. J Hepatol. 67:603–618. 2017.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Phelps M, Coss C, Wang H and Cook M:
Registered report: Coding-independent regulation of the tumor
suppressor PTEN by competing endogenous mRNAs. Elife. 5:e124702016.
View Article : Google Scholar : PubMed/NCBI
|
10
|
Shan TD, Lv SY, Tian ZB, Liu XS, Liu FG
and Sun XG: Knockdown of lncRNA H19 inhibits abnormal
differentiation of small intestinal epithelial cells in diabetic
mice. J Cell Physiol. 234:837–848. 2018. View Article : Google Scholar : PubMed/NCBI
|
11
|
Krishnan P and Damaraju S: The challenges
and opportunities in the clinical application of noncoding RNAs:
The road map for miRNAs and piRNAs in cancer diagnostics and
prognostics. Int J Genomics. 2018:58480462018. View Article : Google Scholar : PubMed/NCBI
|
12
|
Wu S, Sun H, Wang Y, Yang X, Meng Q, Yang
H, Zhu H, Tang W, Li X, Aschner M and Chen R: MALAT1 rs664589
polymorphism inhibits binding to miR-194-5p, contributing to
colorectal cancer risk, growth, and metastasis. Cancer Res.
79:5432–5441. 2019. View Article : Google Scholar : PubMed/NCBI
|
13
|
Wang D, Xu H, Wu B, Jiang S, Pan H, Wang R
and Chen J: Long noncoding RNA MALAT1 sponges miR1243p.1/KLF5 to
promote pulmonary vascular remodeling and cell cycle progression of
pulmonary artery hypertension. Int J Mol Med. 44:871–884.
2019.PubMed/NCBI
|
14
|
Tay Y, Kats L, Salmena L, Weiss D, Tan SM,
Ala U, Karreth F, Poliseno L, Provero P, Di Cunto F, et al:
Coding-independent regulation of the tumor suppressor PTEN by
competing endogenous mRNAs. Cell. 147:344–357. 2011. View Article : Google Scholar : PubMed/NCBI
|
15
|
Cesana M, Cacchiarelli D, Legnini I,
Santini T, Sthandier O, Chinappi M, Tramontano A and Bozzoni I: A
long noncoding RNA controls muscle differentiation by functioning
as a competing endogenous RNA. Cell. 147:358–369. 2011. View Article : Google Scholar : PubMed/NCBI
|
16
|
Thyagarajan A, Shaban A and Sahu RP:
MicroRNA-directed cancer therapies: Implications in melanoma
intervention. J Pharmacol Exp Ther. 364:1–12. 2018. View Article : Google Scholar :
|
17
|
Shan TD, Ouyang H, Yu T, Li JY, Huang CZ,
Yang HS, Zhong W, Xia ZS and Chen QK: miRNA-30e regulates abnormal
differentiation of small intestinal epithelial cells in diabetic
mice by downregulating Dll4 expression. Cell Prolif. 49:102–114.
2016. View Article : Google Scholar : PubMed/NCBI
|
18
|
Hou S, Lin Q, Guan F and Lin C: lncRNA
TNRC6C-AS1 regulates UNC5B in thyroid cancer to influence cell
proliferation, migration, and invasion as a competing endogenous
RNA of miR-129-5p. J Cell Biochem. 119:8304–8316. 2018. View Article : Google Scholar : PubMed/NCBI
|
19
|
Wu C, Zhang X, Chen P, Ruan X, Liu W, Li
Y, Sun C, Hou L, Yin B, Qiang B, et al: MicroRNA-129 modulates
neuronal migration by targeting Fmr1 in the developing mouse
cortex. Cell Death Dis. 10:2872019. View Article : Google Scholar : PubMed/NCBI
|
20
|
Li Z, Lu J, Zeng G, Pang J, Zheng X, Feng
J and Zhang J: MiR-129-5p inhibits liver cancer growth by targeting
calcium calmodulin-dependent protein kinase IV (CAMK4). Cell Death
Dis. 10:7892019. View Article : Google Scholar : PubMed/NCBI
|
21
|
Clevers H, Loh KM and Nusse R: Stem cell
signaling. An integral program for tissue renewal and regeneration:
Wnt signaling and stem cell control. Science. 346:12480122014.
View Article : Google Scholar : PubMed/NCBI
|
22
|
Perochon J, Carroll LR and Cordero JB: Wnt
signalling in intestinal stem cells: Lessons from mice and flies.
Genes (Basel). 9:E1382018. View Article : Google Scholar
|
23
|
Dorfman T, Pollak Y, Sohotnik R, Coran AG,
Bejar J and Sukhotnik I: Enhanced intestinal epithelial cell
proliferation in diabetic rats correlates with beta-catenin
accumulation. J Endocrinol. 226:135–143. 2015. View Article : Google Scholar : PubMed/NCBI
|
24
|
Ouyang H, Yang HS, Yu T, Shan TD, Li JY,
Huang CZ, Zhong W, Xia ZS and Chen QK: MEK/ERK pathway activation
by insulin receptor isoform alteration is associated with the
abnormal proliferation and differentiation of intestinal epithelial
cells in diabetic mice. Mol Cell Biochem. 413:165–178. 2016.
View Article : Google Scholar : PubMed/NCBI
|
25
|
Liu S, Qiu J, He G, Liang Y, Wang L, Liu C
and Pan H: lncRNA MALAT1 acts as a miR-125a-3p sponge to regulate
FOXM1 expression and promote hepatocellular carcinoma progression.
J Cancer. 10:6649–6659. 2019. View Article : Google Scholar : PubMed/NCBI
|
26
|
Zhang J, Li Q, Xue B and He R: MALAT1
inhibits the Wnt/β-catenin signaling pathway in colon cancer cells
and affects cell proliferation and apoptosis. Bosn J Basic Med Sci.
Nov 15–2019.Epub ahead of print. View Article : Google Scholar
|
27
|
Wu X, Li R, Song Q, Zhang C, Jia R, Han Z,
Zhou L, Sui H, Liu X, Zhu H, et al: JMJD2C promotes colorectal
cancer metastasis via regulating histone methylation of
MALAT1promoter and enhancing β-catenin signaling pathway. J Exp
Clin Cancer Res. 38:4352019. View Article : Google Scholar
|
28
|
Brito-Casillas Y, Melian C and Wagner AM:
Study of the pathogenesis and treatment of diabetes mellitus
through animal models. Endocrinol Nutr. 63:345–353. 2016.
View Article : Google Scholar : PubMed/NCBI
|
29
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
30
|
Huang CZ, Xu JH, Zhong W, Xia ZS, Wang SY,
Cheng D, Li JY, Wu TF, Chen QK and Yu T: Sox9 transcriptionally
regulates Wnt signaling in intestinal epithelial stem cells in
hypomethylated crypts in the diabetic state. Stem Cell Res Ther.
8:602017. View Article : Google Scholar : PubMed/NCBI
|
31
|
Gracz AD, Ramalingam S and Magness ST:
Sox9 expression marks a subset of CD24-expressing small intestine
epithelial stem cells that form organoids in vitro. Am J Physiol
Gastrointest Liver Physiol. 298:G590–G600. 2010. View Article : Google Scholar : PubMed/NCBI
|
32
|
Dhamija S and Diederichs S: From junk to
master regulators of invasion: lncRNA functions in migration, EMT
and metastasis. Int J Cancer. 139:269–280. 2016. View Article : Google Scholar : PubMed/NCBI
|
33
|
Lv SY, Shan TD, Pan XT, Tian ZB, Liu XS,
Liu FG, Sun XG, Xue HG, Li XH, Han Y, et al: The lncRNA ZEB1-AS1
sponges miR-181a-5p to promote colorectal cancer cell proliferation
by regulating Wnt/beta-catenin signaling. Cell Cycle. 17:1245–1254.
2018. View Article : Google Scholar :
|
34
|
Yu T, Shan TD, Li JY, Huang CZ, Wang SY,
Ouyang H, Lu XJ, Xu JH, Zhong W and Chen QK: Knockdown of linc-UFC1
suppresses proliferation and induces apoptosis of colorectal
cancer. Cell Death Dis. 7:e22282016. View Article : Google Scholar : PubMed/NCBI
|
35
|
Koren E, Yosefzon Y, Ankawa R, Soteriou D,
Jacob A, Nevelsky A, Ben-Yosef R, Bar-Sela G and Fuchs Y: ARTS
mediates apoptosis and regeneration of the intestinal stem cell
niche. Nat Commun. 9:45822018. View Article : Google Scholar : PubMed/NCBI
|
36
|
Ballantyne MD, McDonald RA and Baker AH:
lncRNA/ MicroRNA interactions in the vasculature. Clin Pharmacol
Ther. 99:494–501. 2016. View Article : Google Scholar : PubMed/NCBI
|
37
|
Adams BD, Parsons C, Walker L, Zhang WC
and Slack FJ: Targeting noncoding RNAs in disease. J Clin Invest.
127:761–771. 2017. View Article : Google Scholar : PubMed/NCBI
|
38
|
Khawar MB, Mehmood R and Roohi N:
MicroRNAs: Recent insights towards their role in male infertility
and reproductive cancers. Bosn J Basic Med Sci. 19:31–42. 2019.
View Article : Google Scholar : PubMed/NCBI
|
39
|
Tian Y, Ma X, Lv C, Sheng X, Li X, Zhao R,
Song Y, Andl T, Plikus MV, Sun J, et al: Stress responsive miR-31
is a major modulator of mouse intestinal stem cells during
regeneration and tumorigenesis. Elife. 6:e295382017. View Article : Google Scholar : PubMed/NCBI
|
40
|
Shaker OG, Abdelwahed MY, Ahmed NA, Hassan
EA, Ahmed TI, Abousarie MA and Ayoub SE: Evaluation of serum long
noncoding RNA NEAT and MiR-129-5p in hepatocellular carcinoma.
IUBMB Life. 71:1571–1578. 2019. View Article : Google Scholar : PubMed/NCBI
|
41
|
Demirsoy İH, Ertural DY, Balci Ş, Çınkır
Ü, Sezer K, Tamer L and Aras N: Profiles of circulating MiRNAs
following metformin treatment in patients with type 2 diabetes. J
Med Biochem. 37:499–506. 2018. View Article : Google Scholar : PubMed/NCBI
|
42
|
Mao J, Hu X, Xiao Y, Yang C, Ding Y, Hou
N, Wang J, Cheng H and Zhang X: Overnutrition stimulates intestinal
epithelium proliferation through beta-catenin signaling in obese
mice. Diabetes. 62:3736–3746. 2013. View Article : Google Scholar : PubMed/NCBI
|
43
|
Bello SA, Torres-Gutiérrez V,
Rodríguez-Flores EJ, Toledo-Román EJ, Rodríguez N, Díaz-Díaz LM,
Vázquez-Figueroa LD, Cuesta JM, Grillo-Alvarado V, Amador A, et al:
Insights into intestinal regeneration signaling mechanisms. Dev
Biol. Feb 1–2020, Epub ahead of print. View Article : Google Scholar
|
44
|
Merenda A, Fenderico N and Maurice MM: Wnt
signaling in 3D: Recent advances in the applications of intestinal
organoids. Trends Cell Biol. 30:60–73. 2020. View Article : Google Scholar
|
45
|
Li H, Zhao Q, Chang L, Wei C, Bei H, Yin
Y, Chen M, Wang H, Liang J and Wu Y: lncRNA MALAT1 modulates ox-LDL
induced EndMT through the Wnt/β-catenin signaling pathway. Lipids
Health Dis. 18:622019. View Article : Google Scholar
|
46
|
Guo C and Wang X, Chen LP, Li M, Li M, Hu
YH, Ding WH and Wang X: Long non-coding RNA MALAT1 regulates
ovarian cancer cell proliferation, migration and apoptosis through
Wnt/β-catenin signaling pathway. Eur Rev Med Pharmacol Sci.
22:3703–3712. 2018.PubMed/NCBI
|